Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 2 385.45 INR 0.15% Market Closed
Market Cap: 20.3B INR
Have any thoughts about
Hester Biosciences Ltd?
Write Note

Intrinsic Value

The intrinsic value of one HESTERBIO stock under the Base Case scenario is 1 589.36 INR. Compared to the current market price of 2 385.45 INR, Hester Biosciences Ltd is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HESTERBIO Intrinsic Value
1 589.36 INR
Overvaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Hester Biosciences Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HESTERBIO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HESTERBIO?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Hester Biosciences Ltd

Provide an overview of the primary business activities
of Hester Biosciences Ltd.

What unique competitive advantages
does Hester Biosciences Ltd hold over its rivals?

What risks and challenges
does Hester Biosciences Ltd face in the near future?

Has there been any significant insider trading activity
in Hester Biosciences Ltd recently?

Summarize the latest earnings call
of Hester Biosciences Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hester Biosciences Ltd.

Provide P/S
for Hester Biosciences Ltd.

Provide P/E
for Hester Biosciences Ltd.

Provide P/OCF
for Hester Biosciences Ltd.

Provide P/FCFE
for Hester Biosciences Ltd.

Provide P/B
for Hester Biosciences Ltd.

Provide EV/S
for Hester Biosciences Ltd.

Provide EV/GP
for Hester Biosciences Ltd.

Provide EV/EBITDA
for Hester Biosciences Ltd.

Provide EV/EBIT
for Hester Biosciences Ltd.

Provide EV/OCF
for Hester Biosciences Ltd.

Provide EV/FCFF
for Hester Biosciences Ltd.

Provide EV/IC
for Hester Biosciences Ltd.

Show me price targets
for Hester Biosciences Ltd made by professional analysts.

What are the Revenue projections
for Hester Biosciences Ltd?

How accurate were the past Revenue estimates
for Hester Biosciences Ltd?

What are the Net Income projections
for Hester Biosciences Ltd?

How accurate were the past Net Income estimates
for Hester Biosciences Ltd?

What are the EPS projections
for Hester Biosciences Ltd?

How accurate were the past EPS estimates
for Hester Biosciences Ltd?

What are the EBIT projections
for Hester Biosciences Ltd?

How accurate were the past EBIT estimates
for Hester Biosciences Ltd?

Compare the revenue forecasts
for Hester Biosciences Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hester Biosciences Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hester Biosciences Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hester Biosciences Ltd compared to its peers.

Compare the P/E ratios
of Hester Biosciences Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hester Biosciences Ltd with its peers.

Analyze the financial leverage
of Hester Biosciences Ltd compared to its main competitors.

Show all profitability ratios
for Hester Biosciences Ltd.

Provide ROE
for Hester Biosciences Ltd.

Provide ROA
for Hester Biosciences Ltd.

Provide ROIC
for Hester Biosciences Ltd.

Provide ROCE
for Hester Biosciences Ltd.

Provide Gross Margin
for Hester Biosciences Ltd.

Provide Operating Margin
for Hester Biosciences Ltd.

Provide Net Margin
for Hester Biosciences Ltd.

Provide FCF Margin
for Hester Biosciences Ltd.

Show all solvency ratios
for Hester Biosciences Ltd.

Provide D/E Ratio
for Hester Biosciences Ltd.

Provide D/A Ratio
for Hester Biosciences Ltd.

Provide Interest Coverage Ratio
for Hester Biosciences Ltd.

Provide Altman Z-Score Ratio
for Hester Biosciences Ltd.

Provide Quick Ratio
for Hester Biosciences Ltd.

Provide Current Ratio
for Hester Biosciences Ltd.

Provide Cash Ratio
for Hester Biosciences Ltd.

What is the historical Revenue growth
over the last 5 years for Hester Biosciences Ltd?

What is the historical Net Income growth
over the last 5 years for Hester Biosciences Ltd?

What is the current Free Cash Flow
of Hester Biosciences Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hester Biosciences Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hester Biosciences Ltd

Current Assets 2.2B
Cash & Short-Term Investments 352.9m
Receivables 999.1m
Other Current Assets 869.9m
Non-Current Assets 4.5B
Long-Term Investments 354.2m
PP&E 4.1B
Intangibles 39.9m
Other Non-Current Assets 20.1m
Current Liabilities 1.3B
Accounts Payable 247.2m
Other Current Liabilities 1B
Non-Current Liabilities 2.4B
Long-Term Debt 1.6B
Other Non-Current Liabilities 807.1m
Efficiency

Earnings Waterfall
Hester Biosciences Ltd

Revenue
3.1B INR
Cost of Revenue
-901.3m INR
Gross Profit
2.2B INR
Operating Expenses
-1.8B INR
Operating Income
470.6m INR
Other Expenses
-235.9m INR
Net Income
234.7m INR

Free Cash Flow Analysis
Hester Biosciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

HESTERBIO Profitability Score
Profitability Due Diligence

Hester Biosciences Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Operating Income
Positive 3-Year Average ROE
48/100
Profitability
Score

Hester Biosciences Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

HESTERBIO Solvency Score
Solvency Due Diligence

Hester Biosciences Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
53/100
Solvency
Score

Hester Biosciences Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HESTERBIO Price Targets Summary
Hester Biosciences Ltd

There are no price targets for HESTERBIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HESTERBIO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HESTERBIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

HESTERBIO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Hester Biosciences Ltd Logo
Hester Biosciences Ltd

Country

India

Industry

Biotechnology

Market Cap

20.3B INR

Dividend Yield

0.25%

Description

Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. The company is headquartered in Ahmedabad, Gujarat and currently employs 584 full-time employees. Its segments include Poultry division and Animal division. The company provides over 40 products across poultry vaccines (live and inactivated), animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. The company manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. The company offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

Contact

GUJARAT
Ahmedabad
Pushpak, Level One,, Panchvati Circle,, Motilal Hirabhai Road,
+917926445107
www.hester.in

IPO

1994-08-17

Employees

584

Officers

Executive CEO, MD & Executive Director
Mr. Rajiv Dinesh Gandhi B.Com
Executive Director
Ms. Priya Gandhi
Chief Financial Officer
Mr. Nikhil Jhanwar
Senior VP of Sales & Marketing and COO
Dr. Ram Prakash
Company Secretary & Compliance Officer
Mr. Vinod Mali
CEO of Hester Biosciences Nepal Private Limited
Dr. Sulochana Shrestha
Show More
Consultant
Dr. Upendra K. Jani
Show Less

See Also

Discover More
What is the Intrinsic Value of one HESTERBIO stock?

The intrinsic value of one HESTERBIO stock under the Base Case scenario is 1 589.36 INR.

Is HESTERBIO stock undervalued or overvalued?

Compared to the current market price of 2 385.45 INR, Hester Biosciences Ltd is Overvalued by 33%.

Back to Top